Home LiteratureArticle Details
PMID: 1469266 Published · ppublish English Journal Article

Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991.

Infection control and hospital epidemiology ·Vol. 13 ·No. 10 ·1992-10-00 ·Pages 582-6

Panlilio AL, Culver DH, Gaynes RP, Banerjee S, Henderson TS, Tolson JS, Martone WJ

Abstract

Analyze changes that have occurred among U.S. hospitals over a 17-year period, 1975 through 1991, in the percentage of Staphylococcus aureus resistant to beta-lactam antibiotics and associated with nosocomial infections. Retrospective review. The percentage of methicillin-resistant S aureus (MRSA) was defined as the number of S aureus isolates resistant to either methicillin, oxacillin, or nafcillin divided by the total number of S aureus isolates for which methicillin, oxacillin, or nafcillin susceptibility test results were reported to the National Nosocomial Infections Surveillance (NNIS) System. NNIS System hospitals. Of the 66,132 S aureus isolates that were tested for susceptibility to methicillin, oxacillin, or nafcillin during 1975 through 1991, 6,986 (11%) were resistant to methicillin, oxacillin, or nafcillin. The percentage MRSA among all hospitals rose from 2.4% in 1975 to 29% in 1991, but the rate of increase differed significantly among 3 bed-size categories: < 200 beds, 200 to 499 beds, and > or = 500 beds. In 1991, for hospitals with < 200 beds, 14.9% of S aureus isolates were MRSA; for hospitals with 200 to 499 beds, 20.3% were MRSA; and for hospitals with > or = 500 beds, 38.3% were MRSA. The percentage MRSA in each of the bed-size categories rose above 5% at different times: in 1983, for hospitals with > or = 500 beds; in 1985, for hospitals with 200 to 499 beds; and in 1987, for hospitals with < 200 beds. This study suggests that hospitals of all sizes are facing the problem of MRSA, the problem appears to be increasing regardless of hospital size, and control measures advocated for MRSA appear to require re-evaluation. Further study of MRSA in hospitals would benefit our understanding of this costly pathogen.

MeSH Terms
Anti-Bacterial Agents/pharmacology Cross Infection/epidemiology,microbiology Hospital Bed Capacity Hospitals/classification,statistics & numerical data,trends Humans Lactams Methicillin Resistance Microbial Sensitivity Tests Staphylococcal Infections/epidemiology,microbiology Staphylococcus aureus/isolation & purification United States/epidemiology
Chemicals
Anti-Bacterial Agents Lactams
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Panlilio A L
Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control, Atlanta, GA 30333.
Culver D H
Gaynes R P
Banerjee S
Henderson T S
Tolson J S
Martone W J
Article Info
Journal
Infection control and hospital epidemiology
Abbr.
Infect Control Hosp Epidemiol
ISSN
0899-823X
Published
1992-10-00
Pages
582-6
Language
English
Region
United States
NLM ID
8804099
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]